CHINAGENE TECH
Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.
CHINAGENE TECH
Industry:
Clinical Trials Enterprise
Founded:
2016-01-01
Address:
Changping, Beijing, China
Country:
China
Website Url:
http://www.chinagene.cc
Total Employee:
11+
Status:
Active
Contact:
010-82071936
Total Funding:
180 M CNY
Technology used in webpage:
SPF Domain Not Resolving HiChina DNS China Telecom Alibaba Cloud MailBox ChinaNet
Similar Organizations
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Genetron Health
Genetron Health is a world-leading expert in precision medicine.
IMPAQ Testing Technology
IMPAQ Testing Technology is an independent third-party testing organization
VitalTrax
VitalTrax connects patients with clinical trials with its cloud-based clinical trial network.
Investors List
Junci Investment
Junci Investment investment in Series A - Chinagene Tech
Yingke Capital
Yingke Capital investment in Series A - Chinagene Tech
Longqian Capital
Longqian Capital investment in Series A - Chinagene Tech
HY Capital
HY Capital investment in Series A - Chinagene Tech
Lotus Lake Ventures
Lotus Lake Ventures investment in Seed Round - Chinagene Tech
Longmen Capital
Longmen Capital investment in Seed Round - Chinagene Tech
Beijing Shoukai Kaiyang Venture Capital Center
Beijing Shoukai Kaiyang Venture Capital Center investment in Corporate Round - Chinagene Tech
Puhua Capital
Puhua Capital investment in Corporate Round - Chinagene Tech
Chiron Ventures
Chiron Ventures investment in Corporate Round - Chinagene Tech
Cowin Capital
Cowin Capital investment in Corporate Round - Chinagene Tech
Official Site Inspections
http://www.chinagene.cc Semrush global rank: 6.8 M Semrush visits lastest month: 783
- Host name: 123.59.154.172
- IP address: 123.59.154.172
- Location: Beijing China
- Latitude: 39.9288
- Longitude: 116.3889
- Timezone: Asia/Shanghai
More informations about "Chinagene Tech"
HUATAO GROUP - en.chinagene.cc
Changping district science and technology research and development organization CHIGENOVO Co., Ltd. is an ophthalmic gene therapy company, a national high-tech enterprise focusing on …See details»
Beijing Chigenovo Co., Ltd. - Drug pipelines, Patents, Clinical trials ...
Www.chinagene.cc. Startups | Holding Company | 2016 | Beijing Shi, China | 10-50 | www.chinagene.cc. Last update 23 Jan 2025. Overview. Pipeline. Deal. Translational …See details»
Chinagene Tech - Crunchbase Company Profile
Chinagene Tech is an ophthalmology clinical genetic diagnosis organization. Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in …See details»
GENE THETAPY - en.chinagene.cc
If you have any additional questions for Expanded Access Program, please feel free to contact Chigenovo by [email protected]. CHIGENOVO Co., Ltd. is an ophthalmic gene …See details»
CHIGENOVO 2025 Company Profile: Valuation, …
CHIGENOVO General Information Description. Developer of clinical genetic diagnosis, fertility prevention and gene therapy drug for hereditary eye diseases. The company specializes in developing ophthalmic gene therapy drugs …See details»
Beijing Chigenovo Co., Ltd. (北京中因科技有限公司) - 药物管线_专 …
Mar 7, 2025 了解Beijing Chigenovo Co., Ltd. (北京中因科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的3项临床试验，疾病领域:神经系统疾病，技术平台:基因疗法，腺相关病 …See details»
Beijing Zhongyin Technology (Chinagene) - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
遗传 - chinagene.cn
M 6 A(N 6-甲基腺嘌呤)是mRNA中含量最丰富的化学修饰之一，在动植物发育和各种生理病理过程中发挥关键性的作用。然而作为一条相对较新的RNA修饰通路，可能还存在未被发现的成员。因此，探索新的m 6 A修饰通路成员有助于完善人 …See details»
Chinagene Tech - Overview, News & Similar companies - ZoomInfo
Chinagene Tech is a company that operates in the Biotechnology industry. It employs 11-20 people and has $1M-$5M of revenue. The company is headquartered in Changping, Beijing, …See details»
Chinagene Tech - Golden
Chinagene Tech is a Beijing-based company founded in 2016. Overview Structured Data Issues Contributors Activity. Contents. chinagene.cc. Is a. Company. Organization. Company …See details»
Clinical trial-CHIGENOVO Co., Ltd. Drug development|Ophthalmic …
If you have any additional questions for Expanded Access Program, please feel free to contact Chigenovo by [email protected]. CHIGENOVO Co., Ltd. is an ophthalmic gene …See details»
HUATAO GROUP - en.chinagene.cc
CHIGENOVO Co., Ltd. Drug development|Ophthalmic diseases Submitted successfully A national high-tech enterprise engaged in clinical gene diagnosis and gene therapy drug research and …See details»
Beijing Zhongyin Technology (Chinagene) - VentureRadar
Similar Companies: Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, …See details»
中因科技-动脉网 - vbdata.cn
Jan 18, 2016 [email protected] 北京中因科技有限公司是一家专业从事遗传性眼病临床基因诊断、生育预防和基因治疗药物研发的国家高新技术企业，是国内率先进行眼科基因 …See details»
北京中因科技有限公司 - 爱企查
爱企查为您提供北京中因科技有限公司的企业信息查询服务，查询北京中因科技有限公司工商注册信息、电话邮箱、公司地址、经营风险、控股持股、发展动态、财务状况、股东法人高管、商 …See details»
北京中因科技有限公司 药物研发|眼科疾病
北京中因科技有限公司是专注从事遗传眼病基因治疗药物开发和基因诊断的国家高新技术企业，致力于为遗传性眼病患者提供精准诊断和治疗“一站式”解决方案。See details»
CNGBdb: China National GeneBank DataBase - chinagene.cn
Contact: Wang Ren,Xu Xun,Wei Xiaofeng E-mail:[email protected];[email protected];[email protected] Supported by: …See details»
重磅！中因科技体内基因编辑治疗药物ZVS203e注射液获国家药监 …
Feb 8, 2024 公司网址： www.chinagene.cc — 往期精彩 — 患者招募| 结晶样视网膜变性(BCD)受试者; 患者招募|视网膜色素变性(RHO基因突变)受试者; 研发进展|ZVS101e I/II期临床试验完成 …See details»
HUATAO GROUP - en.chinagene.cc
A national high-tech enterprise engaged in clinical gene diagnosis and gene therapy drug research and development for hereditary eye diseasesSee details»
临床试验-北京中因科技有限公司 药物研发|眼科疾病
If you have any additional questions for Expanded Access Program, please feel free to contact Chigenovo by [email protected]. 北京中因科技有限公司是眼科基因治疗企业，专 …See details»